Skip to Content

Pro Medicus Ltd PMCUF

Morningstar Rating
$65.75 −1.75 (2.59%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PMCUF is trading at a 97% premium.
Price
$65.68
Fair Value
$15.75
Uncertainty
High
1-Star Price
$31.84
5-Star Price
$73.97
Economic Moat
Tcpzsn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PMCUF is a good fit for your portfolio.

Trading Information

Previous Close Price
$67.50
Day Range
$65.7566.72
52-Week Range
$38.1970.75
Bid/Ask
$61.91 / $68.09
Market Cap
$6.87 Bil
Volume/Avg
700 / 925

Key Statistics

Price/Earnings (Normalized)
148.45
Price/Sales
72.92
Dividend Yield (Trailing)
0.34%
Dividend Yield (Forward)
0.23%
Total Yield
0.35%

Company Profile

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Large Growth
Total Number of Employees
75

Competitors

Valuation

Metric
PMCUF
NAN
RMD
Price/Earnings (Normalized)
148.4555.3627.15
Price/Book Value
63.314.936.22
Price/Sales
72.925.296.05
Price/Cash Flow
145.0836.3822.52
Price/Earnings
PMCUF
NAN
RMD

Financial Strength

Metric
PMCUF
NAN
RMD
Quick Ratio
7.345.261.23
Current Ratio
7.496.563.11
Interest Coverage
12.4619.71
Quick Ratio
PMCUF
NAN
RMD

Profitability

Metric
PMCUF
NAN
RMD
Return on Assets (Normalized)
35.76%9.04%14.83%
Return on Equity (Normalized)
50.95%11.94%24.40%
Return on Invested Capital (Normalized)
48.23%9.96%18.31%
Return on Assets
PMCUF
NAN
RMD
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockDfdlmfm$42.2 Bil
VEEV
Veeva Systems Inc Class AXxdmh$36.4 Bil
MTHRF
M3 IncCygpcq$9.8 Bil
MTHRY
M3 Inc ADRQnmyhvl$9.8 Bil
HQY
HealthEquity IncKvzfgn$7.1 Bil
RCM
R1 RCM IncCzhy$5.9 Bil
DOCS
Doximity Inc Class AMsfcdf$5.3 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AMwy$5.3 Bil
EVH
Evolent Health Inc Class ABfzhxq$4.0 Bil

Sponsor Center